SU898956A3 - Method of preparing benzo (b) thiophene-2 derivatives or their salts - Google Patents
Method of preparing benzo (b) thiophene-2 derivatives or their salts Download PDFInfo
- Publication number
- SU898956A3 SU898956A3 SU782468109D SU2468109D SU898956A3 SU 898956 A3 SU898956 A3 SU 898956A3 SU 782468109 D SU782468109 D SU 782468109D SU 2468109 D SU2468109 D SU 2468109D SU 898956 A3 SU898956 A3 SU 898956A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carbon atoms
- oxo
- benzo
- alkyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
38 где R,X и Х имеют вышеуказанные зна чени , подвергают взаимодействию с дибромал каном общей формулы BrCHR (СН2)цВг, гдеВ/(И п имеют указанные значени , последующей обработкой амином fl J. Однако в литературе отсутствуют сведени о способе получени фармако логически активных производных бензо в тиофенона-2 общей формулы 1 или их солейi Цель изобретени - разработка спо соба получени производных бензо| в тиофенона-2 общей формулы 1 или их солей, обладающих ценными свойствами Поставленна цель достигаетс описываемым способом получени произ водных бензо в1тиофенона-2 общей формулы 1 или их солей, заключающимс в том, что соединение общей формулы О-СКо, r CHCNR R О SH где R,R и R имеют вышеуказанные значени ; R - низша алкоксигруппа, галоген, анилиногруппа замещенна галогеном, подвергают циклизации при и в случае необходимости в присутствии кислоты с последующим выделением целевого продукта в свободном виде или в виде соли. Соединени общей формулы 1 про вл ют периферийное анальгетическое и противовоспалительное действие. Эти соединени обладают также урикосурическим и антитромбозным действием. В св зи с этим их можно примен ть пр лечении артритов, подагры и в качестве тромболитических средств. Пример 1. 7,7-Диамид-М, (3 хлоранил.ида) 2- (о-меркаптофенил -малоновой кислоты раствор ют в 50 мл диметилсульфоксида, добавл ют 0,5 г концентрированной серной кислоты и перемешивают в течение ночи при 50с. К реакционной смеси добавл ют 100 мл диэтилового эфира и промывают сначала разбавленным раствором едкого натра а затем водой, высушивают сульфатом натри , упаривают , хроматографируют на силикагеле и перекристаллизовывают из эфира, получают N-(З-хлорфеиил)-2-оксо-2,3-бензо{ в тиофенкарбоксамид , т .пло 175-176,. Это соединение получают также из 2- (о-меркаптофенил)малонилхлорид-N- (З-хлоранилида), который нагревают с хлорсульфоновой кислотой в тетрагидрофуране в течение 3 ч до 150С, и полученный N-(З-хлоранилид)-метиловый эфир 2-(о-меркаптофенил)-малоновой кислоты нагревают в ацетамиде в течение 3 ч при 120°С, после описанной обработки реакционной смеси получают N-(З-хлорфенил)-2-оксо-2,3 -бензо в тиофенкарбоксамид. В аналогичных услови х получают следующие соединени общей формулы 1: N-(2,дихлорфенил)-2-оксо-2,3 -дигидро-3-бен3о в тиофенкарбоксамид , с Топл. 201-203 С; N-(4-метоксифенил)-2-оксо-2,3 -дигидро-3-бензо в тиофенкарбоксамид, G т.пл„ 181-183°С; N-(2-метилфенил)-2-оксо-2,3 ДИгидро-3 бензо в тиофенкарбоксамид с ТоПл. 153-155°С; N-(3,5-бистрифторметилфенил)-2-оксо-2 ,3-дигидро-3-бензо в -тиофенкарбоксамид с т.пл, 1б9-171°С; Н-(-метилфенил)-2-оксо-2,3-дигидро-3 бензо в тиофенкарбоксамид с |Т.пл. 17б-179С; N-(-этоксифенил)-2-ОКСО-2 , 3-дигидро-3 бензо в тиофенкарбоксамид с т.пл. HS-ISI C; N-(4-бромфенил)-2-ОКСО-2,3-Дигидpo-3 6eH3ofв тиофенкарбоксамид с т.пл. 178-180°С; N-(3(Зметилизоксазолил)-2 оксо-2 ,3 ДИГИдро-2-бензо в тиофенилкарбоксамид с т.пло ISt-lSo С; N-(2-метоксикарбонилфенил)-2-оксо-2 ,3 Дигидро-3-бензо в тиофенкарбоксамид с т.пл. , а также путем гидролиза последнего: N-(2-карбоксифенил )-2-оксо-2,3-ди гидро-3-бензо в тиофенкэрбоксамид , N (3 ,4-диметоксифенил)-2-оксо-2 ,3-дигидро-3 бензо в тиофенкарбоксамид с т„пл. ISt-ISG C; N-(2-метоксифенил)-2-оксо-2,3 -дигидро 3-бензо в тиофенкарбоксамид с т.пл. 1itO-U2C; N (3 ДИхлорфенил)-2-оксо-2,3-дигидро-3 бензо в тиофенкарбоксамид с т.пл. 192-19 °С; М-бутил-2,3-Дигидро-2-оксо-3-бензо в тиофенкарбоксамид; Н-бензил-2,З-дигидро-2-оксо-бензо в тиофенкарбоксамид;38 where R, X and X have the above values, they are reacted with dibromal kan of the general formula BrCHR (CH2) cBr, where B / (And n have the indicated values, followed by treatment with fl J amine. However, in the literature, there are no pharmacologically active benzo derivatives in thiophenone-2 of general formula 1 or their salts. The purpose of the invention is to develop a method for producing benzo [derivatives] in thiophenone-2 of general formula 1 or their salts with valuable properties. The goal is achieved by the described method of producing benzo-1-thiophenone-2 of the general formula 1 or their salts, consisting in that the compound of the general formula O-Co, r CH 2 NR R O SH where R, R and R have the above-mentioned values subjected to cyclization with and, if necessary, in the presence of acid, followed by isolation of the target product in free form or as a salt. Compounds of general formula 1 exhibit peripheral analgesic and anti-inflammatory effects. These compounds also have a uricosuric and antithrombotic effect. Therefore, they can be used for the treatment of arthritis, gout and as thrombolytic agents. Example 1. 7,7-Diamide-M, (3 chloranyl.id) 2- (o-mercapto-phenylmalonic acid is dissolved in 50 ml of dimethyl sulfoxide, 0.5 g of concentrated sulfuric acid is added and stirred overnight at 50 ° C. To the reaction mixture are added 100 ml of diethyl ether and washed first with a dilute sodium hydroxide solution and then with water, dried with sodium sulfate, evaporated, chromatographed on silica gel and recrystallized from ether to give N- (3-chloro-feiyl) -2-oxo-2,3 -benzo {in thiophene-carboxamide, mp 175-176 ,. This compound is also obtained from 2- (o-mer aptophenyl) malonyl chloride-N- (3-chloroanilide), which is heated with chlorosulfonic acid in tetrahydrofuran for 3 hours to 150 ° C, and the resulting N- (3-chloroanilide) methyl 2- (o-mercaptophenyl) -malonic acid ester is heated in acetamide for 3 hours at 120 ° C, after the treatment of the reaction mixture described above, N- (3-chlorophenyl) -2-oxo-2,3-benzo in thiophene-carboxamide is obtained. Under similar conditions, the following compounds of the general formula 1: N- ( 2, dichlorophenyl) -2-oxo-2,3-dihydro-3-ben3o to thiophenecarboxamide, with Topl. 201-203 C; N- (4-methoxyphenyl) -2-oxo-2,3-dihydro-3-benzo in thiophenecarboxamide, G m.p. „181-183 ° С; N- (2-methylphenyl) -2-oxo-2,3 dihydro-3 benzo in thiophenecarboxamide with Topl. 153-155 ° C; N- (3,5-bistrifluoromethylphenyl) -2-oxo-2, 3-dihydro-3-benzo in -thiophencarboxamide with m.p., 1b9-171 ° C; H - (- Methylphenyl) -2-oxo-2,3-dihydro-3 benzo in thiophenecarboxamide with | T. mp. 17b-179C; N - (- ethoxyphenyl) -2-OXO-2, 3-dihydro-3 benzo in thiophencarboxamide with so pl. HS-ISI C; N- (4-bromophenyl) -2-OXO-2,3-Dihydro-3 6eH3of in thiophencarboxamide with so pl. 178-180 ° C; N- (3 (Zmethylisoxazolyl) -2 oxo-2, 3 DIGIDRO-2-benzo in thiophenylcarboxamide with m.p. ISt-lSo C; N- (2-methoxycarbonylphenyl) -2-oxo-2, 3 Dihydro-3-benzo in thiophenecarboxamide with m.pl., and also by hydrolysis of the latter: N- (2-carboxyphenyl) -2-oxo-2,3-di-hydro-3-benzo to thiophenecarboxamide, N (3, 4-dimethoxyphenyl) -2- oxo-2, 3-dihydro-3 benzo in thiophenecarboxamide with m „PL. ISt-ISG C; N- (2-methoxyphenyl) -2-oxo-2,3-dihydro 3-benzo in thiophene carboxamide with mp 1itO -U2C; N (3 Dichlorophenyl) -2-oxo-2,3-dihydro-3 benzo in thiophenecarboxamide with mp 192-19 ° C; M-butyl-2,3-Dihydro-2-oxo-3- benzo in thiophenecarboxamide; H- enzil-2, Z-dihydro-2-oxo-benzo into thiophenecarboxamide;
N-(Зхпорфенил)-5-хлор-2,3-Дигидро-2-оксо-6ензо в тиофенкарбоксамид с т.пл. 1бО-1бЗС;N- (Zhporpenil) -5-chloro-2,3-dihydro-2-oxo-6enzo in thiophenecarboxamide with so pl. 1bO-1bZS;
N- (2-тиазолил)-5 хлор-2,3 дигидро-2-оксо-бензо в1тиофенкарбоксамид с т.пло 29б-299°С;N- (2-thiazolyl) -5 chloro-2.3 dihydro-2-oxo-benzo-1 thiophene carboxamide with a temperature of 29b-299 ° C;
N-фенил-5 хлор-2,3 дигидро-2-оксо-бензо в тиофенкарбоксамид с т.пл„ 170-1724;,N-phenyl-5 chloro-2,3 dihydro-2-oxo-benzo in thiophene-carboxamide with tpl 170-1724;
N- ( -этоксифенил) -5-хлор-2 ,3-ДИгидро-2-оксо-З-бензо в тиофенкарбоксамид с т.пл о 202-205С;N- (-ethoxyphenyl) -5-chloro-2, 3-DiHydro-2-oxo-3-benzo in thiophenecarboxamide, mp: 202-205С;
Н-(2-фторфенил)-5-хлор-2,3-Дигидро-2-оксо-3-бензо в тиофенкарбоксами с Топл. 205-207С;N- (2-fluorophenyl) -5-chloro-2,3-dihydro-2-oxo-3-benzo in thiophencarboxes with Topl. 205-207С;
М-фенил-5-карбокси-2,3 Дигидро-2-оксо-3-бензо в тиофенкарбоксамид;M-phenyl-5-carboxy-2,3 dihydro-2-oxo-3-benzo to thiophenecarboxamide;
N-(2-метилфенил)-5 карбокси-2,3-дигидро-2-оксо-3-бензо| в тиофенкарбоксамид;N- (2-methylphenyl) -5 carboxy-2,3-dihydro-2-oxo-3-benzo | in thiophencarboxamide;
N-(2-метилфенил)-5-карбокси-2,3 -дигидро-2-оксо-3-бензоГв тиофенкарбоксамид;N- (2-methylphenyl) -5-carboxy-2,3-dihydro-2-oxo-3-benzoHv thiophenecarboxamide;
N-(2-хлорфенил)-5-карбокси-2,3 дигидро-2-оксо-2-бензо в тиофенкарбоксамид;N- (2-chlorophenyl) -5-carboxy-2,3-dihydro-2-oxo-2-benzo to thiophenecarboxamide;
N-(3 хлорфенил)-5 карбокси-2,3-ди гидро-2-оксо-3-бензо в тиофенкарбоксамид , а также их метиловый эфир;N- (3 chlorophenyl) -5 carboxy-2,3-di hydro-2-oxo-3-benzo to thiophenecarboxamide, as well as their methyl ester;
М-(2-фтарфенил)-6-хлор-2,3-Дигидро-2-оксо-3-бензо в 3тиофенкарбоксами с т.пло 187-190 С;M- (2-phtarphenyl) -6-chloro-2,3-Dihydro-2-oxo-3-benzo in 3thiofencarboxes with mp of 187-190 ° C;
Н-фенил-6-хлор-2,З-дигидро-2-оксо-3-бензо в1тиофенкарбоксамид с т.пл, 01-20ifC;H-phenyl-6-chloro-2, 3-dihydro-2-oxo-3-benzo-1-thiophene-carboxamide with m.p., 01-20if C;
N-(З-хлорфенил)-б-хлор-2,3-дигидро-2-оксо-3-бензо в тиофенкарбоксами с т„пл, 212-215°С;N- (3-chlorophenyl) -b-chloro-2,3-dihydro-2-oxo-3-benzo in thiophencarboxes with m „PL, 212-215 ° C;
N-.{2-хлорфенил)-6-хлор-2,3-дигидро-2-оксо-З-бензо в тиофенкарбоксами с т«пл 1б9-170С;N -. {2-chlorophenyl) -6-chloro-2,3-dihydro-2-oxo-3-benzo in thiophencarboxes with m pl 1b9-170C;
М-фенил-2,3-Дигидро-6-метокси-2-оксо-3-бензо| в тиофенкарбоксамид; M-phenyl-2,3-dihydro-6-methoxy-2-oxo-3-benzo | in thiophencarboxamide;
N-(2-хлорфенил)-2,З-ДИГидро-6-метокси-2-оксо-3 6ензоГв1тиофенкарбоксамид;N- (2-chlorophenyl) -2, 3-diHydro-6-methoxy-2-oxo-3 6-benzo-Hl thiophene carboxamide;
N-(3 хлорфенил)-2,3-дигидро-6-метокси-2-оксо-3-бензоГв тиофенкарбоксамид;N- (3 chlorophenyl) -2,3-dihydro-6-methoxy-2-oxo-3-benzoHv thiophenecarboxamide;
М-(2-фторфенил)-2,3-ДИгидpo-6-мeтoкcи-2-oкco-3-бeнзo вJтиoфeнкapбoкcaмид;M- (2-Fluorophenyl) -2,3-Dyhydro-6-methoxy-2-oxo-3-Benzo-b-thiofenccarbamide;
N-(2-фторфенил)-2,3-дигидро-6чметокси-2-оксо-3-бензо в IT иофенкарбоксамид;N- (2-fluorophenyl) -2,3-dihydro-6-hmethoxy-2-oxo-3-benzo in IT iofencarboxamide;
N-фeнил-2,3 Дигидро-5-нитро-2-оксо-3 бензо в тиофенкарбоксамид;N-phenyl-2,3 dihydro-5-nitro-2-oxo-3 benzo to thiophenecarboxamide;
N-(2-хлорфенил)-2,3-дигидро-5-нитро-2-оксо-3-бензо в тиофенкарбоксамид;N- (2-chlorophenyl) -2,3-dihydro-5-nitro-2-oxo-3-benzo to thiophenecarboxamide;
N-(З-хлорфенил)-2,3 Дигидро-5-нитро-2-оксо-3-бензо в тиофенкарбоксамид;N- (Z-chlorophenyl) -2,3 Dihydro-5-nitro-2-oxo-3-benzo to thiophenecarboxamide;
N-(2-фторфенил)-2,З-Дигидро-5-нитро-2-оксо-3-бензоГв тиофенкарбоксамиД .N- (2-fluorophenyl) -2, 3-dihydro-5-nitro-2-oxo-3-benzoV in thiophencarboxamide.
Приме р2. К кип щей суспензии 7 г М-(3-хлорфенил)-2-оксо-2,3 -дигидро-3-бензоГв тиофенкарбоксамид в 200 мл ацетона добавл ют 2 мл морфолина , причем вс суспензи раствор етс . Прозрачный раствор охлаждают и разбавл ют 250 мл петролейного эфира, кристаллизуетс морфолинова соль М-(3-хлорфенил)-2-оксо-2,3 дигидро-3-бензо в тиофенкарбоксамида , которую отфильтровывают и сушат, т.пл, 1 72-1 73, С.Take p2. To a boiling suspension of 7 g of M- (3-chlorophenyl) -2-oxo-2,3-dihydro-3-benzoGv thiophenecarboxamide in 200 ml of acetone was added 2 ml of morpholine, and the entire suspension was dissolved. The clear solution is cooled and diluted with 250 ml of petroleum ether, the morpholine salt of M- (3-chlorophenyl) -2-oxo-2,3 dihydro-3-benzoic crystallizes in thiophene-carboxamide, which is filtered and dried, mp: 1 72-1 73, C.
Пример 3. 2,2 г М-(3-хлорфенил ) -2-ОКСО-2 ,3 Дигидро-3-бензо в } тиофенкарбоксамида умеренно нагревают в смеси из 7,5 мл 1 Но раствора едкого натра и 30 мл воды, причем при температуре около все раствор етс , К раствору добавл ют 1,1 г гептагидрата сульфата цинка в 5 мл -ВОДЫ, отфильтровывают через 30 мин. кристаллический осадок цинковой соли N-(З-хлорфенил)-2-ОКСО-2,3 дигидро-3 бензо| в тиофенкарбоксамида и сушат ее. Соль имеет т.пло около 172 С (с выделением газа).Example 3. 2.2 g of M- (3-chlorophenyl) -2-OXO-2, 3 Dihydro-3-benzo c} thiophene carboxamide is heated moderately in a mixture of 7.5 ml 1 But sodium hydroxide solution and 30 ml of water, moreover at a temperature of about everything is dissolved, 1.1 g of zinc sulfate heptahydrate in 5 ml of WATER is added to the solution, filtered after 30 minutes. crystalline precipitate of zinc salt of N- (Z-chlorophenyl) -2-OXO-2,3 dihydro-3 benzo | in thiofencarboxamide and dry it. Salt has a melting point of about 172 ° C (with evolution of gas).
Пример А. 20 г N-(З-хлорфенил ) -2-ОКСО-2,3-дигидро-3-бензо вJтиофенкарбоксамида суспендируют в 250 мл ацетона и смешивают с 6,6 н,раствора едкого натра, после чего образуетс раствор. Упаривают досуха, остаток после упаривани перемешивают сначала с толуолом, а затем с диэтило.вым эфиром, отсасывают, и высушивают. Получают натриевую соль N-(З-хлорфенил)-2-оксо-2,3-ДИГидро-3-бензо в1тиофенкарбоксамида с ТоПл. выше .Example A. 20 g of N- (3-chlorophenyl) -2-OXO-2,3-dihydro-3-benzo-b-thiophene-carboxamide are suspended in 250 ml of acetone and mixed with 6.6 N sodium hydroxide solution, after which a solution is formed. It is evaporated to dryness, the residue after evaporation is stirred first with toluene, and then with diethyl ether, sucked off, and dried. The sodium salt of N- (3-chlorophenyl) -2-oxo-2,3-diHydro-3-benzo-1-thiophene-carboxamide is obtained with Topl. above .
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH453876A CH630082A5 (en) | 1976-04-09 | 1976-04-09 | METHOD FOR PRODUCING OXOTHIA COMPOUNDS. |
CH1599476A CH629797A5 (en) | 1976-12-20 | 1976-12-20 | Process for the preparation of salts of oxothia compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SU898956A3 true SU898956A3 (en) | 1982-01-15 |
Family
ID=25695718
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772468109A SU795475A3 (en) | 1976-04-09 | 1977-04-06 | Method of preparing 2,3-dihydrobenzo/b/thiophenones-2 or their salts |
SU782468109D SU898956A3 (en) | 1976-04-09 | 1978-02-06 | Method of preparing benzo (b) thiophene-2 derivatives or their salts |
SU782576952A SU791239A3 (en) | 1976-04-09 | 1978-02-08 | Method of preparing 2,3-dihydrobenzo(b)thiophenone-2 derivatives or their salts |
SU782612600A SU738510A3 (en) | 1976-04-09 | 1978-05-11 | Method of preparing 2,3-dihydrobenzo/b/-thiophenones-2 or their salts |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772468109A SU795475A3 (en) | 1976-04-09 | 1977-04-06 | Method of preparing 2,3-dihydrobenzo/b/thiophenones-2 or their salts |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU782576952A SU791239A3 (en) | 1976-04-09 | 1978-02-08 | Method of preparing 2,3-dihydrobenzo(b)thiophenone-2 derivatives or their salts |
SU782612600A SU738510A3 (en) | 1976-04-09 | 1978-05-11 | Method of preparing 2,3-dihydrobenzo/b/-thiophenones-2 or their salts |
Country Status (27)
Country | Link |
---|---|
US (1) | US4320138A (en) |
JP (1) | JPS52125158A (en) |
AR (3) | AR218869A1 (en) |
AT (1) | AT357148B (en) |
CA (1) | CA1112248A (en) |
CS (4) | CS207394B2 (en) |
CY (1) | CY1138A (en) |
DD (1) | DD130659A5 (en) |
DE (1) | DE2713584C2 (en) |
DK (1) | DK152046C (en) |
ES (1) | ES457528A1 (en) |
FI (1) | FI69461C (en) |
FR (1) | FR2347363A1 (en) |
GB (1) | GB1544339A (en) |
GR (1) | GR70652B (en) |
HK (1) | HK6182A (en) |
HU (1) | HU180438B (en) |
IE (1) | IE44987B1 (en) |
IL (1) | IL51847A (en) |
KE (1) | KE3185A (en) |
MY (1) | MY8200244A (en) |
NL (1) | NL7703802A (en) |
NO (1) | NO146810C (en) |
NZ (1) | NZ183747A (en) |
PL (3) | PL110653B1 (en) |
SE (1) | SE432930B (en) |
SU (4) | SU795475A3 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH634840A5 (en) * | 1978-06-29 | 1983-02-28 | Ciba Geigy Ag | 2-OXO-2,3-DIHYDRO-BENZO (B) THIOPHENE COMPOUND AND PHARMACEUTICAL PREPARATIONS MADE THEREOF. |
AT392787B (en) * | 1978-06-29 | 1991-06-10 | Ciba Geigy Ag | Process for the preparation of novel N-(2-thienyl)-2-oxo- 2,3-dihydrobenzo(b)thiophene-3-carboxamide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3413308A (en) * | 1966-09-02 | 1968-11-26 | Dow Chemical Co | Substituted benzo(b)thiophene-2-carboxanilides |
US3655693A (en) * | 1969-06-25 | 1972-04-11 | Merck & Co Inc | Anti-inflammatory salicyclic acid derivatives |
US3676463A (en) * | 1970-10-15 | 1972-07-11 | Pfizer | Oxobenzofuran carboxamides |
US3971814A (en) * | 1972-11-27 | 1976-07-27 | Warner-Lambert Company | Benzo(b)thiophene derivatives |
GB1571847A (en) * | 1974-01-02 | 1980-07-23 | Systems Eng & Mfg | Waste water treatment |
-
1977
- 1977-03-28 DE DE2713584A patent/DE2713584C2/en not_active Expired
- 1977-03-31 NZ NZ183747A patent/NZ183747A/en unknown
- 1977-04-01 GB GB13857/77A patent/GB1544339A/en not_active Expired
- 1977-04-01 CY CY1138A patent/CY1138A/en unknown
- 1977-04-04 FI FI771044A patent/FI69461C/en not_active IP Right Cessation
- 1977-04-05 ES ES457528A patent/ES457528A1/en not_active Expired
- 1977-04-06 DK DK158777A patent/DK152046C/en not_active IP Right Cessation
- 1977-04-06 SE SE7704033A patent/SE432930B/en not_active IP Right Cessation
- 1977-04-06 SU SU772468109A patent/SU795475A3/en active
- 1977-04-06 GR GR53186A patent/GR70652B/el unknown
- 1977-04-06 NL NL7703802A patent/NL7703802A/en not_active Application Discontinuation
- 1977-04-06 NO NO771231A patent/NO146810C/en unknown
- 1977-04-07 CS CS772337A patent/CS207394B2/en unknown
- 1977-04-07 IE IE741/77A patent/IE44987B1/en not_active IP Right Cessation
- 1977-04-07 CS CS772337A patent/CS207392B2/en unknown
- 1977-04-07 CS CS772337A patent/CS207393B2/en unknown
- 1977-04-07 FR FR7710590A patent/FR2347363A1/en active Granted
- 1977-04-07 CA CA275,837A patent/CA1112248A/en not_active Expired
- 1977-04-07 DD DD7700198312A patent/DD130659A5/en unknown
- 1977-04-07 CS CS772337A patent/CS207395B2/en unknown
- 1977-04-08 PL PL1977197311A patent/PL110653B1/en unknown
- 1977-04-08 HU HU77CI1728A patent/HU180438B/en unknown
- 1977-04-08 AT AT248577A patent/AT357148B/en not_active IP Right Cessation
- 1977-04-08 PL PL1977204751A patent/PL111459B1/en unknown
- 1977-04-08 IL IL51847A patent/IL51847A/en unknown
- 1977-04-08 PL PL1977204750A patent/PL111456B1/en unknown
- 1977-04-09 JP JP3998877A patent/JPS52125158A/en active Granted
- 1977-04-11 AR AR267166A patent/AR218869A1/en active
-
1978
- 1978-02-06 SU SU782468109D patent/SU898956A3/en active
- 1978-02-08 SU SU782576952A patent/SU791239A3/en active
- 1978-02-14 AR AR271100A patent/AR224614A1/en active
- 1978-02-14 AR AR271101A patent/AR225401A1/en active
- 1978-05-11 SU SU782612600A patent/SU738510A3/en active
-
1980
- 1980-12-08 US US06/214,168 patent/US4320138A/en not_active Expired - Lifetime
-
1982
- 1982-02-08 KE KE3185A patent/KE3185A/en unknown
- 1982-02-11 HK HK61/82A patent/HK6182A/en unknown
- 1982-12-30 MY MY244/82A patent/MY8200244A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4863922A (en) | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use | |
DE3882732T2 (en) | Indole, benzofuran, benzothiophene-containing lipoxygenase inhibiting compounds. | |
US4556672A (en) | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
IL189383A (en) | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene, process for their preparation, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments for the treatment of central nervous system disorders | |
NZ501577A (en) | Method for making (+)-(S)-(2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid methyl ester and salts thereof, process characterised by use of methyl hydrogen sulfate | |
FI76797B (en) | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA TIADIAZINON-, OXADIAZINON- OCH TRIAZINONDERIVAT. | |
US4721712A (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
GB1594079A (en) | 1-acyl-2-cyanoaziridines | |
US4076709A (en) | Thienothiazines | |
US3743656A (en) | Thiophene and furan lower alkanoic acids and derivatives | |
EP0318682B1 (en) | Tricyclic thiazole derivatives | |
SU725558A3 (en) | Method of preparing n-(1,3,4-thiadiazol-2-yl)benzamide derivatives | |
IE41457B1 (en) | Thienothiazine derivatives | |
DD234417A5 (en) | PROCESS FOR THE PREPARATION OF 1,3-DISUBSTITUTED 2-OXINDOELS AS ANALYTICAL AND ANTI-INHIBITING AGENTS | |
US3362962A (en) | Certain benzothiazepine derivatives | |
SU898956A3 (en) | Method of preparing benzo (b) thiophene-2 derivatives or their salts | |
EP0340010B1 (en) | Heterocyclic nitromethane derivatives | |
DK155009B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF THIENOOE2,3-EAA-1,2-THIAZIN-1,1-DIOXIDE DERIVATIVE OR PHARMACEUTICAL TOLERABLE SALTS AND THE PRESENT MATERIALS FOR USING THE PROCEDURE | |
KR860001874B1 (en) | Process for 2-oxindole-1-carboxamide and intermediates thereof | |
PT89268B (en) | PROCESS FOR THE PREPARATION OF HETEROCYCLIC OXOFTALAZINYL ACETTIC ACIDS | |
GB2169893A (en) | Benzofuran and benzothiophene derivatives | |
NO146710B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENYL PIPERAZINE DERIVATIVES | |
GB2154585A (en) | Prodrugs of antiinflammatory oxicams | |
DD232039A5 (en) | PROCESS FOR PREPARING A 2-OXINIDOL-1-CARBOXAMIDE COMPOUND | |
FR2728571A1 (en) | NOVEL TRICYCLIC OXIMES ETHERS, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |